Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

Archive ouverte

Keiser, Olivia | Tweya, Hannock | Boulle, Andrew | Braitstein, Paula | Schechter, Mauro | Brinkhof, Martin, W.G. | Dabis, François | Tuboi, Suely | Sprinz, Eduardo | Pujades-Rodriguez, Mar | Calmy, Alexandra | Kumarasamy, Nagalingeswaran | Nash, Denis | Jahn, Andreas | Macphail, Patrick | Lüthy, Ruedi | Wood, Robin | Egger, Matthias

Edité par CCSD ; Wolters Kluwer -

International audience. BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia. DESIGN AND METHODS: Multicohort study of 17 ART programmes. All sites monitored CD4 cell count and had access to second-line ART and 10 sites monitored viral load. We compared times to switching, CD4 cell counts at switching and obtained adjusted hazard ratios for switching (aHRs) with 95% confidence intervals (CIs) from random-effects Weibull models. RESULTS: A total of 20 113 patients, including 6369 (31.7%) patients from 10 programmes with access to viral load monitoring, were analysed; 576 patients (2.9%) switched. Low CD4 cell counts at ART initiation were associated with switching in all programmes. Median time to switching was 16.3 months [interquartile range (IQR) 10.1-26.6] in programmes with viral load monitoring and 21.8 months (IQR 14.0-21.8) in programmes without viral load monitoring (P < 0.001). Median CD4 cell counts at switching were 161 cells/microl (IQR 77-265) in programmes with viral load monitoring and 102 cells/microl (44-181) in programmes without viral load monitoring (P < 0.001). Switching was more common in programmes with viral load monitoring during months 7-18 after starting ART (aHR 1.38; 95% CI 0.97-1.98), similar during months 19-30 (aHR 0.97; 95% CI 0.58-1.60) and less common during months 31-42 (aHR 0.29; 95% CI 0.11-0.79). CONCLUSION: In resource-limited settings, switching to second-line regimens tends to occur earlier and at higher CD4 cell counts in ART programmes with viral load monitoring compared with programmes without viral load monitoring.

Suggestions

Du même auteur

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.: Tuberculosis on antiretroviral therapy

Archive ouverte | Brinkhof, Martin, W.G. | CCSD

International audience. We examined the incidence of and risk factors for tuberculosis during the first year of highly active antiretroviral therapy in low-income (4540 patients) and high-income (22,217 patients) co...

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Archive ouverte | Brinkhof, Martin, W.G. | CCSD

International audience. OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resource-limited settings. METHODS: Using data on 5491 adult patients starting ART (median age 3...

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Archive ouverte | Nash, Denis | CCSD

International audience. BACKGROUND: Few data are available on the long-term immunologic response to antiretroviral therapy (ART) in resource-limited settings, where ART is being rapidly scaled up using a public heal...

Chargement des enrichissements...